A Registered Cohort Study on FSHD1
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNing Wang, MD., PhD.
About this trial
The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.
Eligibility criteria
Qualifiers
Male or female subjects of all ages at baseline
Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting
Unrelated healthy controls
Disqualifiers
Decline to participate
Other neuromuscular disease (such as Limb-girdle muscular dystrophy or Myotonic dystrophy)
Serious systemic illness (such as heart, liver, kidney disease or major mental illness)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Ning Wang, MD., PhD.
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Sponsor institution
Source ClinicalTrials.gov